Literature DB >> 4339634

Preliminary clinical trials of dichloromethotrexate (NSC-29630) in hepatocellular carcinoma.

C L Vogel, R H Adamson, V T DeVita, D G Johns, S K Kyalwazi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4339634

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  3 in total

1.  Intraarterial hepatic chemotherapy with fluorouracil, fluorodeoxyuridine, mitomycin C, cisplatin or methotrexate as single-agent anticancer drugs for a transplanted experimental liver tumor in rats.

Authors:  S Kurth; D Bulian; B Kreft; T Riemenschneider
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

2.  19F-n.m.r. studies of 3',5'-difluoromethotrexate binding to Lactobacillus casei dihydrofolate reductase. Molecular motion and coenzyme-induced conformational changes.

Authors:  G M Clore; A M Gronenborn; B Birdsall; J Feeney; G C Roberts
Journal:  Biochem J       Date:  1984-02-01       Impact factor: 3.857

3.  Evaluation of weekly escalating doses of dichloromethotrexate in patients with hepatocellular carcinoma and other solid tumors.

Authors:  W J Tester; R C Donehower; J L Eddy; C E Myers; D C Ihde
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.